-+ 0.00%
-+ 0.00%
-+ 0.00%

LONGEVERON ANNOUNCES UPDATED RESULTS FROM ELPIS II PHASE 2B CLINICAL TRIAL EVALUATING LAROMESTROCEL AS A POTENTIAL TREATMENT FOR HYPOPLASTIC LEFT HEART SYNDROME (HLHS)

Reuters·10/26/2026 13:15:00

Please log in to view news